X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (67527) 67527
Newspaper Article (14563) 14563
Newsletter (646) 646
Web Resource (616) 616
Book Chapter (511) 511
Magazine Article (483) 483
Book / eBook (220) 220
Trade Publication Article (131) 131
Dissertation (73) 73
Conference Proceeding (37) 37
Book Review (29) 29
Reference (25) 25
Publication (21) 21
Streaming Video (17) 17
Government Document (9) 9
Transcript (4) 4
Paper (2) 2
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (45714) 45714
autoimmune diseases (36335) 36335
female (23686) 23686
animals (19824) 19824
male (19212) 19212
immunology (16488) 16488
adult (13391) 13391
middle aged (12347) 12347
disease (10462) 10462
mice (10445) 10445
multiple sclerosis (8790) 8790
autoimmune diseases - immunology (8754) 8754
inflammation (8261) 8261
autoimmunity (8243) 8243
aged (7493) 7493
research (7016) 7016
rheumatology (6776) 6776
rheumatoid arthritis (6195) 6195
experimental autoimmune encephalomyelitis (6134) 6134
patients (6088) 6088
cytokines (6081) 6081
autoimmune diseases - drug therapy (5913) 5913
lymphocytes (5811) 5811
immune system (5479) 5479
autoantibodies (5260) 5260
medicine (5244) 5244
lupus (5230) 5230
neurosciences (5163) 5163
medical research (5145) 5145
immunotherapy (4955) 4955
antibodies (4942) 4942
autoimmune diseases - therapy (4941) 4941
adolescent (4921) 4921
care and treatment (4914) 4914
clinical trials (4756) 4756
analysis (4662) 4662
proteins (4572) 4572
health aspects (4561) 4561
diagnosis (4512) 4512
disease models, animal (4447) 4447
therapy (4419) 4419
t cells (4348) 4348
cancer (4316) 4316
arthritis (4290) 4290
risk factors (4246) 4246
treatment outcome (4243) 4243
antigens (4228) 4228
research article (4142) 4142
pathogenesis (4128) 4128
rheumatoid-arthritis (4079) 4079
expression (4025) 4025
multiple-sclerosis (3978) 3978
child (3959) 3959
immunoglobulins (3928) 3928
immunosuppressive agents - therapeutic use (3823) 3823
studies (3782) 3782
systemic lupus erythematosus (3707) 3707
medicine & public health (3695) 3695
hematology (3675) 3675
multidisciplinary sciences (3614) 3614
t-cells (3448) 3448
clinical neurology (3359) 3359
diabetes (3336) 3336
dendritic cells (3297) 3297
gastroenterology & hepatology (3211) 3211
medicine, general & internal (3195) 3195
cell biology (3174) 3174
systemic-lupus-erythematosus (3164) 3164
neurology (3129) 3129
autoimmune diseases - diagnosis (3101) 3101
mice, inbred c57bl (3092) 3092
lymphocytes t (3075) 3075
rats (3028) 3028
autoimmune (3023) 3023
oncology (2999) 2999
t-lymphocytes - immunology (2995) 2995
gene expression (2994) 2994
pharmacology & pharmacy (2986) 2986
young adult (2976) 2976
science (2952) 2952
pharmaceutical industry (2922) 2922
drug therapy (2917) 2917
internal medicine (2880) 2880
central-nervous-system (2878) 2878
medicine, research & experimental (2864) 2864
autoimmune diseases - complications (2847) 2847
autoimmune disease (2824) 2824
experimental allergic encephalomyelitis (2789) 2789
review (2779) 2779
abridged index medicus (2639) 2639
apoptosis (2638) 2638
regulatory t-cells (2638) 2638
development and progression (2602) 2602
rodents (2590) 2590
retrospective studies (2568) 2568
endocrinology & metabolism (2507) 2507
pathology (2505) 2505
pediatrics (2502) 2502
autoantibodies - blood (2492) 2492
activation (2482) 2482
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (93) 93
Online Resources - Online (54) 54
Collection Dvlpm't (Acquisitions) - Vendor file (22) 22
Collection Dvlpm't (Acquisitions) - Closed Orders (8) 8
UofT at Scarborough - Stacks (4) 4
UofT at Mississauga - Stacks (3) 3
Scarborough Hospital - General (2) 2
Scarborough Hospital - Online (2) 2
St. Michael's Hospital - Stacks (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
Trinity College (John W Graham) - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Cancelled Order (1) 1
Gerstein Science - Searching (1) 1
Holland Bloorview Kids Rehabilitation - Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Trillium Health Centre - Reserve desk (1) 1
Trinity College (John W Graham) - Storage (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (80787) 80787
German (1438) 1438
French (890) 890
Japanese (676) 676
Spanish (504) 504
Russian (486) 486
Polish (247) 247
Italian (181) 181
Chinese (169) 169
Portuguese (126) 126
Korean (77) 77
Hungarian (73) 73
Czech (56) 56
Dutch (50) 50
Norwegian (44) 44
Danish (37) 37
Hebrew (34) 34
Turkish (33) 33
Swedish (32) 32
Serbian (27) 27
Romanian (26) 26
Croatian (24) 24
Finnish (17) 17
Slovak (15) 15
Ukrainian (12) 12
Bulgarian (11) 11
Arabic (5) 5
Slovenian (5) 5
Bosnian (3) 3
Persian (3) 3
Belarusian (1) 1
Hindi (1) 1
Indonesian (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature reviews. Neurology, ISSN 1759-4766, 2011, Volume 7, Issue 3, pp. 165 - 172
..., with rituximab, alemtuzumab and efalizumab. The prevalence of demyelinating disease induced by biological therapies, as reported in randomized controlled trials and postmarketing studies, has been estimated to range from 0.02-0.20... 
RHEUMATOID-ARTHRITIS | PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY | ADALIMUMAB | DISEASE | GLOBAL CLINICAL-TRIALS | PERIPHERAL NEUROPATHY | NECROSIS-FACTOR-ALPHA | MECHANISMS | VASCULITIS | INFLIXIMAB THERAPY | CLINICAL NEUROLOGY | Leukoencephalopathy, Progressive Multifocal - immunology | Peripheral Nervous System Diseases - chemically induced | Leukoencephalopathy, Progressive Multifocal - prevention & control | Humans | Antibodies, Monoclonal - adverse effects | Autoimmune Diseases - complications | Antibodies, Monoclonal - therapeutic use | Demyelinating Diseases - prevention & control | Leukoencephalopathy, Progressive Multifocal - chemically induced | Nervous System Diseases - prevention & control | Peripheral Nervous System Diseases - prevention & control | Demyelinating Diseases - immunology | Tumor Necrosis Factor-alpha - immunology | Product Surveillance, Postmarketing | Nervous System Diseases - chemically induced | Demyelinating Diseases - chemically induced | Autoimmune Diseases - chemically induced | Nervous System Diseases - immunology | Peripheral Nervous System Diseases - immunology | Autoimmune Diseases - drug therapy | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Nervous system diseases | Care and treatment | Tumor necrosis factor | Monoclonal antibodies | Physiological aspects | Research | Health aspects
Journal Article
Journal of hepatology, ISSN 0168-8278, 2009, Volume 51, Issue 2, pp. 237 - 267
...1 Introduction EASL Clinical Practice Guidelines (CPG) on the management of cholestatic liver diseases define the use of diagnostic, therapeutic and preventive... 
Gastroenterology and Hepatology | Primary biliary cirrhosis | Intrahepatic cholestasis of pregnancy | Immunoglobulin G4-associated cholangitis | Overlap syndrome | Cholestatic liver diseases in pregnancy | Primary sclerosing cholangitis | Fatigue | Drug-induced cholestatic liver disease | Pruritus | Genetic cholestatic liver disease | MODIFIED SCORING SYSTEM | DOSE URSODEOXYCHOLIC ACID | BLIND CONTROLLED-TRIAL | ENDOSCOPIC RETROGRADE CHOLANGIOGRAPHY | HEPATITIS OVERLAP SYNDROME | RANDOMIZED-CONTROLLED-TRIALS | PRIMARY BILIARY-CIRRHOSIS | PLACEBO-CONTROLLED TRIAL | GASTROENTEROLOGY & HEPATOLOGY | FAMILIAL INTRAHEPATIC CHOLESTASIS | Osteoporosis - therapy | Liver Cirrhosis, Biliary - therapy | Humans | Infant | Male | Cholangitis - immunology | Osteoporosis - etiology | Cholestasis, Intrahepatic - prevention & control | Cholestasis, Intrahepatic - etiology | Adult | Female | Child | Hepatitis, Autoimmune - therapy | Hepatitis, Autoimmune - diagnosis | Cholangitis - diagnosis | Pregnancy Complications - diagnosis | Cystic Fibrosis - complications | Syndrome | Pregnancy | Liver Cirrhosis, Biliary - diagnosis | Cholangitis, Sclerosing - therapy | Cholestasis, Intrahepatic - diagnosis | Cholangitis, Sclerosing - diagnosis | Cholangitis - therapy | Cholestasis, Intrahepatic - therapy | Immunoglobulin G - metabolism | Pregnancy Complications - therapy | Practice guidelines (Medicine) | Liver cancer | Diagnostic imaging | Phosphatases | Immunoglobulin G | Ulcerative colitis
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 11/2014, Volume 73, Issue 11, pp. 1942 - 1948
Objectives To determine among patients with autoimmune diseases in the USA whether the risk of non-viral opportunistic infections (OI... 
DMARDs (biologic) | Infections | Tuberculosis | Rheumatoid Arthritis | TNF-alpha | RHEUMATOID-ARTHRITIS | PNEUMOCYSTIS PNEUMONIA | RISK-FACTORS | SERIOUS BACTERIAL-INFECTIONS | FACTOR-ALPHA ANTAGONISTS | GRANULOMATOUS INFECTIONS | BRITISH-SOCIETY | RHEUMATOLOGY | INFLIXIMAB | ANTIBODY THERAPY | MYCOBACTERIAL DISEASES | United States - epidemiology | Biological Therapy - methods | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Opportunistic Infections - chemically induced | Arthritis, Rheumatoid - drug therapy | Antirheumatic Agents - adverse effects | Adult | Biological Products - adverse effects | Female | Opportunistic Infections - immunology | Retrospective Studies | Autoimmune Diseases - drug therapy | Antirheumatic Agents - therapeutic use | Biological Products - therapeutic use | Autoimmune Diseases - epidemiology | Opportunistic Infections - epidemiology | Arthritis, Rheumatoid - epidemiology | Autoimmune Diseases - immunology | Biological Therapy - adverse effects | Immunosuppressive Agents - adverse effects | Aged | Immunocompromised Host | Arthritis, Rheumatoid - immunology | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Complications and side effects | Care and treatment | Opportunistic infections | Tumor necrosis factor inhibitors | Dosage and administration | Autoimmune diseases | Risk factors | Codes | Bacterial infections | Medicare | Lung diseases | Inflammatory bowel disease | Immunotherapy | Pharmacy | Gangrene | Tumor necrosis factor-TNF | Medicaid | Viral infections | Pharmaceuticals
Journal Article